Royal Bank of Canada’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11
Closed 6855
2024
Q2
$0 Hold
11
﹤0.01% 7051
2024
Q1
$0 Hold
11
﹤0.01% 7014
2023
Q4
$0 Hold
11
﹤0.01% 7110
2023
Q3
$0 Buy
11
+1
+10% +$10 ﹤0.01% 7081
2023
Q2
$0 Sell
10
-1
-9% -$11 ﹤0.01% 7247
2023
Q1
$0 Buy
+11
New +$172 ﹤0.01% 7073
2022
Q4
Sell
-5
Closed 7218
2022
Q3
$0 Buy
+5
New +$137 ﹤0.01% 7440
2022
Q1
Sell
-1
Closed 7726
2021
Q4
$0 Buy
+1
New +$109 ﹤0.01% 7646

Other funds holding BFRI

Royal Bank of Canada's BFRI Position: Q3 2024 in Review

Royal Bank of Canada sold out of Biofrontera (BFRI) in Q3 2024, closing a stake of 11 shares.

Royal Bank of Canada first reported a position in BFRI in Q4 2021 and held it in 8 quarters. The position peaked at $0 in Q2 2024. 9 funds tracked by Wall St. Rank hold BFRI as of Q3 2024.

  • Royal Bank of Canada reported no remaining Biofrontera position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 11 Biofrontera shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Biofrontera in Q4 2021 and held it in 8 quarters.
  • Royal Bank of Canada's Biofrontera position peaked at $0 in Q2 2024.
  • 9 funds tracked by Wall St. Rank held Biofrontera as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.